Thursday, May 05, 2011 4:51:49 PM
NewCardio Among MDB Capital Group's Small-Cap IP Leaders
SANTA CLARA, Calif., May 2, 2011 /PRNewswire/ -- NewCardio, Inc., (OTC BB: NWCI) a cardiac diagnostic technology provider, today announced its selection for the prestigious NYC Bright Lights Conference at the Le Parker Meridien Hotel in New York City. Bright Lights is the only conference of its kind with an exclusive focus on publicly traded companies with disruptive and market changing intellectual property (IP). NewCardio will present on May 10, 2011 at 9 a.m. ET.
NewCardio was selected from MDB's 2011 group of "Best and Brightest" small-cap companies, a group that is advancing some of today's most innovative and market-leading intellectual property (IP). It is one of the 40 public companies ranking in the 90th percentile for its respective technology leadership from more than 1,500 small-cap companies with granted U.S. patents, as rated by PatentVest, MDB's proprietary IP business intelligence platform.
Christopher Marlett, CEO at MDB Capital Group, comments, "It's a rare and exciting opportunity to have so many key players that are driving IP asset monetization together under one roof and we look forward to sharing NewCardio's cardiac diagnostic technology with other innovators and investors at the Bright Lights conference."
Bright Lights also features high-profile speakers including the top IP experts in the nation, such as David Kappos, Under Secretary of Commerce for Intellectual Property and Director of the United States Patent and Trademark Office (USPTO), who will be joining as a keynote speaker; in addition to Marshall Phelps, former head of Microsoft IP, and John Cronin, former head of IBM's Patent Factory, and Paul Ryan of Acacia Research.
The second annual Bright Lights Conference will take place on May 10 - 11th at the Le Parker Meridien Hotel in New York City. To learn more about the event, please visit: http://www.mdb.com.
Investors and other interested parties may access an audio only webcast of the live presentation at http://www.wsw.com/webcast/mdb2/nwci.ob/. This webcast will be archived for 90 days following the live presentation.
About MDB Capital Group
MDB Capital Group, LLC is an institutional research and investment banking firm focusing exclusively on small and micro-cap companies possessing market changing, disruptive intellectual property. For more information on MDB Capital Group, visit: http://www.mdb.com
About PatentVest
PatenVest® is a proprietary intellectual property (IP) business intelligence platform developed by MDB Capital Group. PatentVest quantifies the appropriate valuation of IP and enables the emergence of IP as an investible asset class. For more information on PatentVest please visit: http://www.patentvest.com
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM